Furthermore, it provides more comprehensive data, allowing detection of rare tumor entities that are easily to be misclassified using conventional techniques, in addition to further identify the more indolent IDH-wildtype gliomas from molecular glioblastoma without the need for additional analyses. The gene discussed is IDH1; the disease is glioma.